Imaeda says
Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market
We monitor your labs, muscle mass, and organ function to ensure you are losing fat, not muscle, and doing so safely
Semaglutide may cause serious side effects, including possible thyroid tumors and thyroid cancer
Instead, companies are using compounding pharmacies to bypass the FDA-approved manufacturers and generate profit
Both of these medications contain semaglutide, a synthetic version of the GLP-1 hormone, but they are prescribed at different doses depending on the patients medical needs